Hepatic cholesterol transport and its role in non-alcoholic fatty liver disease and atherosclerosis

2021/06/11 by Heng Li, Xiao-Hua Yu, Xiang Ou +3 · 1 citation
Biochemistry, Genetics and Molecular Biology · Medicine · #Cancer, Lipids, and Metabolism #Cholesterol and Lipid Metabolism #Liver Disease Diagnosis and Treatment

paper · doi:10.1016/j.plipres.2021.101109

openalex publication_date 2021/06/11 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/28

Citations

• Scavenger receptor-BI is a receptor for lipoprotein(a)
• Regulation of HMG-CoA reductase in mammals and yeast
• Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7α‐hydroxylase gene expression†
• Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis
• Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
• Bile acid analysis in human disorders of bile acid biosynthesis
• Berberine alleviates hepatic lipid accumulation by increasing ABCA1 through the protein kinase C δ pathway

Cited by

• Lipidomics in pathogenesis, progression and treatment of nonalcoholic steatohepatitis (NASH): Recent advances